T

Theragen Etex Co Ltd
KOSDAQ:066700

Watchlist Manager
Theragen Etex Co Ltd
KOSDAQ:066700
Watchlist
Price: 3 115 KRW -0.95% Market Closed
Market Cap: 115.7B KRW

Theragen Etex Co Ltd
Treasury Stock

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Theragen Etex Co Ltd
Treasury Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Treasury Stock CAGR 3Y CAGR 5Y CAGR 10Y
T
Theragen Etex Co Ltd
KOSDAQ:066700
Treasury Stock
-â‚©1.8B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
3%
Yuhan Corp
KRX:000100
Treasury Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Treasury Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Treasury Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Treasury Stock
-â‚©568.1m
CAGR 3-Years
34%
CAGR 5-Years
22%
CAGR 10-Years
12%
C
Caregen Co Ltd
KOSDAQ:214370
Treasury Stock
-â‚©72.2B
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
No Stocks Found

Theragen Etex Co Ltd
Glance View

Market Cap
114.3B KRW
Industry
Pharmaceuticals

THERAGEN ETEX Co., Ltd. engages in the manufacture and sale of pharmaceutical products and in the provision of genome sequencing services. The company is headquartered in Ansan, Gyeonggi-Do. The company went IPO on 2004-05-27. is a Korea-based company engaged in the industrial equipment business, healthcare and genome business and pharmaceutical business. The firm operates its business through three divisions: flat panel display (FPD) manufacturing equipment division, which provides loading and unloading systems, printed circuit board (PCB) bonding systems, battery washing lines and laser systems; healthcare and genome division engages in the provision of genome analysis services and others, and pharmaceutical division engages in the manufacture of digestive system remedies, antibiotics, remedies for fever, circulatory system remedies, respiration system remedies, treatment for chronic hepatitis, diabetes remedies, psychotropic agents, osteoporosis treatments and others.

Intrinsic Value
6 182.71 KRW
Undervaluation 50%
Intrinsic Value
Price
T

See Also

What is Theragen Etex Co Ltd's Treasury Stock?
Treasury Stock
-1.8B KRW

Based on the financial report for Jun 30, 2025, Theragen Etex Co Ltd's Treasury Stock amounts to -1.8B KRW.

What is Theragen Etex Co Ltd's Treasury Stock growth rate?
Treasury Stock CAGR 10Y
3%

Over the last year, the Treasury Stock growth was 0%.

Back to Top